Exploratory PK and Imaging Study of PSMA-Targeted Trillium Compounds and PTI-122 in Metastatic Prostate Cancer
Clinical trial NCT05773703 · COMPLETED
Trial details
- NCT number
- NCT05773703
- Sponsor
- Ratio Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-08
- Primary completion
- 2023-12-12
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.